Keeler Thomas Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.77M Buy
134,168
+17,134
+15% +$456K 1.59% 13
2025
Q4
$2.91M Buy
117,034
+14,899
+15% +$376K 1.39% 17
2025
Q3
$2.6M Buy
102,135
+2,778
+3% +$68.6K 1.06% 24
2025
Q2
$2.41M Buy
+99,357
New +$2.32M 1.04% 20
2023
Q1
Sell
-50,369
Closed -$2.58M 83
2022
Q4
$2.58M Sell
50,369
-2,429
-5% -$116K 1.3% 37
2022
Q3
$2.31M Buy
+52,798
New +$2.57M 1.17% 36
2021
Q1
Sell
-69,739
Closed -$2.57M 83
2020
Q4
$2.57M Sell
69,739
-14,205
-17% -$521K 1.44% 30
2020
Q3
$2.91M Buy
83,944
+8,757
+12% +$307K 1.84% 25
2020
Q2
$2.39M Buy
+75,187
New +$2.55M 1.73% 25
2018
Q1
Sell
-1,897
Closed -$65K 118
2017
Q4
$65K Buy
+1,897
New +$64.7K 0.06% 79

Other funds holding PFE

Keeler Thomas Management's PFE Position: Q1 2026 in Review

Keeler Thomas Management increased its Pfizer (PFE) stake by 15% in Q1 2026, buying an estimated $456K and bringing the position to 134,168 shares worth $3.77M. The position accounts for 1.59% of the portfolio, ranked #13.

Keeler Thomas Management first reported a position in PFE in Q4 2017 and has held it in 10 quarters since. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Keeler Thomas Management held 134,168 shares of Pfizer worth $3.77M as of Q1 2026.
  • Keeler Thomas Management bought 17,134 Pfizer shares in Q1 2026, an estimated $456K.
  • Pfizer made up 1.59% of Keeler Thomas Management's portfolio in Q1 2026, its #13 holding.
  • Keeler Thomas Management first reported a position in Pfizer in Q4 2017 and has held it in 10 quarters since.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Keeler Thomas Management's 13F filing for Q1 2026, filed 12 May 2026.